Vir Biotechnology Announces New Clinical Data From its

– Results from ongoing trials of VIR-2218 and VIR-3434 presented at the International Liver Congress™ (ILC) 2022 demonstrate durable reductions in...

Related Keywords

,Liver Congress ,Nasdaq Vir ,Vir Biotechnology ,Nc ,Gbv ,Hepatitis B ,Liver Conference ,The Liver Meeting ,